Search research articles
Contact Us
Filters
Showing results (51-60 of 67) with videos related to
Page
of 7
Sort By:
Therapeutic Advances in Medical Oncology
|
September 24, 2020
Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: a multi-centre North London experience
Nalinie Joharatnam-Hogan, Daniel Hochhauser, Kai-Keen Shiu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2020
Geographic and Ethnic Heterogeneity of Germline <i>BRCA1</i> or <i>BRCA2</i> Mutation Prevalence Among Patients With Metastatic Pancreatic Cancer Screened for Entry Into the POLO Trial
Talia Golan, Hedy L Kindler, Joon Oh Park, et al.
Therapeutic Advances in Medical Oncology
|
November 12, 2020
COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort study
Valerie E Crolley, Daire Hanna, Nalinie Joharatnam-Hogan, et al.
Health Technology Assessment (Winchester, England)
|
May 7, 2020
Liver resection surgery compared with thermal ablation in high surgical risk patients with colorectal liver metastases: the LAVA international RCT
Brian Davidson, Kurinchi Gurusamy, Neil Corrigan, et al.
British Journal of Cancer
|
November 9, 2022
PANTHER: AZD8931, inhibitor of EGFR, ERBB2 and ERBB3 signalling, combined with FOLFIRI: a Phase I/II study to determine the importance of schedule and activity in colorectal cancer
David J Propper, Fangfei Gao, Mark P Saunders, et al.
Cancer Discovery
|
May 25, 2015
Tracking the genomic evolution of esophageal adenocarcinoma through neoadjuvant chemotherapy
Nirupa Murugaesu, Gareth A Wilson, Nicolai J Birkbak, et al.
Trials
|
February 15, 2018
Liver resection surgery versus thermal ablation for colorectal LiVer MetAstases (LAVA): study protocol for a randomised controlled trial
Kurinchi Gurusamy, Neil Corrigan, Julie Croft, et al.
Journal of the National Cancer Institute
|
December 19, 2019
HER2-HER3 Heterodimer Quantification by FRET-FLIM and Patient Subclass Analysis of the COIN Colorectal Trial
Paul R Barber, Gregory Weitsman, Katherine Lawler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 14, 2022
Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Hedy L Kindler, Pascal Hammel, Michele Reni, et al.
The New England Journal of Medicine
|
June 4, 2019
Maintenance Olaparib for Germline <i>BRCA</i>-Mutated Metastatic Pancreatic Cancer
Talia Golan, Pascal Hammel, Michele Reni, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 67) with videos related to
Sort By:
Page
of 7
Therapeutic Advances in Medical Oncology
|
September 24, 2020
Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: a multi-centre North London experience
Nalinie Joharatnam-Hogan, Daniel Hochhauser, Kai-Keen Shiu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2020
Geographic and Ethnic Heterogeneity of Germline <i>BRCA1</i> or <i>BRCA2</i> Mutation Prevalence Among Patients With Metastatic Pancreatic Cancer Screened for Entry Into the POLO Trial
Talia Golan, Hedy L Kindler, Joon Oh Park, et al.
Therapeutic Advances in Medical Oncology
|
November 12, 2020
COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort study
Valerie E Crolley, Daire Hanna, Nalinie Joharatnam-Hogan, et al.
Health Technology Assessment (Winchester, England)
|
May 7, 2020
Liver resection surgery compared with thermal ablation in high surgical risk patients with colorectal liver metastases: the LAVA international RCT
Brian Davidson, Kurinchi Gurusamy, Neil Corrigan, et al.
British Journal of Cancer
|
November 9, 2022
PANTHER: AZD8931, inhibitor of EGFR, ERBB2 and ERBB3 signalling, combined with FOLFIRI: a Phase I/II study to determine the importance of schedule and activity in colorectal cancer
David J Propper, Fangfei Gao, Mark P Saunders, et al.
Cancer Discovery
|
May 25, 2015
Tracking the genomic evolution of esophageal adenocarcinoma through neoadjuvant chemotherapy
Nirupa Murugaesu, Gareth A Wilson, Nicolai J Birkbak, et al.
Trials
|
February 15, 2018
Liver resection surgery versus thermal ablation for colorectal LiVer MetAstases (LAVA): study protocol for a randomised controlled trial
Kurinchi Gurusamy, Neil Corrigan, Julie Croft, et al.
Journal of the National Cancer Institute
|
December 19, 2019
HER2-HER3 Heterodimer Quantification by FRET-FLIM and Patient Subclass Analysis of the COIN Colorectal Trial
Paul R Barber, Gregory Weitsman, Katherine Lawler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 14, 2022
Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Hedy L Kindler, Pascal Hammel, Michele Reni, et al.
The New England Journal of Medicine
|
June 4, 2019
Maintenance Olaparib for Germline <i>BRCA</i>-Mutated Metastatic Pancreatic Cancer
Talia Golan, Pascal Hammel, Michele Reni, et al.
Page
of 7